Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Nov 29, 2023 10:58am
71 Views
Post# 35758588

RE:RE:RE:RE:The big one...

RE:RE:RE:RE:The big one...
Tencents wrote: No mention of qtr backlog of sales being caught up
Guess it's not going to happen despite indications in prior qtr releases 


Last quarter CZO thought it was lagging the previous year's revenue by one quarter. With the quarter announced today it is lagging 2 quarters. Given we are two months into Q3 and they didn't announce re-ordering had re-commenced it looks like they are now lagging at least three quarters. If no reordering in Q1 2024 that would be one year lagging. Did Kenvue have twice as much inventory built up as a COVID precaution in case of supply chain disruptions? Is Kenvue trying to get more aggressive in its supply chain managment so as to hold less inventory than J&J did to generate efficiencies? During the presentation last month Gilles anticipated a return to historical trends for the base business as Kenvue works through its adjustment in 2023. CZO is also preparing the lanuch of a dry powder oat beta glucan and avenanthramide to reach new markets.  

<< Previous
Bullboard Posts
Next >>